Abstract:Per- and polyfluoroalkyl substances (PFAS) have received global attention as an important group of industrial additives. They had been widely used in various commercial and industrial products resulted in ubiquitous distribution in the environment and frequent exposure to wildlife and humans. During recent decades, efforts have been made globally to eliminate legacy PFAS, such as perfluorooctanoic acid (PFOA) and perfluorooctane sulfonic acid (PFOS), due to their persistence, bioaccumulation, and toxicity. Other than the well-known PFOA and PFOS, an increasing list of emerging PFAS has been applied, but received insufficient investigation on their sources, environmental distributions and health risks. Thus, identification and characterization of emerging PFAS become critical to PFAS research. Follicular fluid is an important microenvironment for oocyte development and has an important impact on reproductive health. PFAS may penetrate the blood-follicular fluid barrier and enter the follicular fluid and result in potential adverse effects on reproductive health. In the present study, we screened for emerging PFAS in follicular fluid based on non-target analysis with liquid chromatography-high-resolution mass spectrometer. Follicular fluid samples from 99 Chinese women seeking in vitro fertilization-embryo transfer treatment were analysed. The workflow for non-target screening of PFAS mainly includes chromatographic peak picking, blank feature filtering, automatic PFAS annotation, confidence level annotation and manual review. The PFAS and confidence level annotations were mainly based on the following evidences: Exact precursor ion masses, characteristic fragment ion masses, homologous series, retention time, mass defect values. After applying the workflow, a total of 26 PFAS were identified in pooled follicular fluid samples, among which 17 were PFAS with reference standards and nine were emerging PFAS including two chlorinated chlorinated polyfluoroalkyl ether sulfonic acids (Cl-PFESAs), and seven hydrosubstituted polyfluoroalkyl carboxylic acids (H-PFCAs). The two novel Cl-PFESAs, 4:2 Cl-PFESAs and 5:2 Cl-PFESA had detection frequencies higher than 90%, and their semi-quantification concentrations were comparable to those of 8:2 Cl-PFESA. Four H-PFCAs (H-PFHpA, H-PFOA, H-PFNA and H-PFUdA) had detection frequencies higher than 50%, and they all exhibited low semi-quantification concentrations. There is limited information on the sources and commercial use of these emerging PFASs. We speculate that the two Cl-PFESAs and H-PFCAs may originate from the transformation of Cl-PFESA congeners and PFCAs, in the environment or in organisms, respectively. However, these need to be confirmed by further research. Blood-follicular fluid transfer efficiency (BFTE) of these emerging PFAS was also determined. The median BFTE of 4:2 Cl-PFESAs and 5:2 Cl-PFESA were 0.86 and 0.92, respectively, which were close to the BFTE of 6:2 Cl-PFESA (0.92), indicating substantial trend in crossing the blood-follicle barrier. The BFTE of H-PFCAs (1.01 for H-PFHpA, 0.96 for H-PFOA, 1.02 for H-PFNA, 0.76 for H-PFUdA and 0.56 for H-PFDoA) exhibited a significant decreasing trend along with the increase of carbon chains, which was consistent with the pattern of BFTE of PFCAs of the same population. Our data lay a solid ground for further screening of emerging PFAS and exploration of their potential impact on reproductive health.

Associations between perfluorinated alkyl acids in blood and ovarian follicular fluid and ovarian function in women undergoing assisted reproductive treatment

Per- and Polyfluoroalkyl Substances (PFAS) Exposure in Women Seeking in Vitro Fertilization-Embryo Transfer Treatment (IVF-ET) in China: Blood-follicular Transfer and Associations with IVF-ET Outcomes

Perfluorinated alkyl acids in the serum and follicular fluid of UK women with and without polycystic ovarian syndrome undergoing fertility treatment and associations with hormonal and metabolic parameters

Nontargeted Identification of Per- and Polyfluoroalkyl Substances in Human Follicular Fluid and Their Blood-Follicle Transfer

Effect of PFOA exposure on diminished ovarian reserve and its metabolism

Non-target Screening of Per- and Polyfluoroalkyl Substances in Follicular Fluid and Their Blood-Follicle Transfer

Parental Plasma Concentrations of Perfluoroalkyl Substances and in Vitro Fertilization Outcomes.

Association between Perfluoroalkyl Substances in Follicular Fluid and Polycystic Ovary Syndrome in Infertile Women

Associations between lifestyle factors and levels of per- and polyfluoroalkyl substances (PFASs), phthalates and parabens in follicular fluid in women undergoing fertility treatment

Exposure of women undergoing in-vitro fertilization to per-and polyfluoroalkyl substances: Evidence on negative effects on fertilization and high-quality embryos

Follicular fluid and blood levels of persistent organic pollutants and reproductive outcomes among women undergoing assisted reproductive technologies

Perfluoroalkyl Substances Exposure and Risk of Polycystic Ovarian Syndrome Related Infertility in Chinese Women.

Association between per- and polyfluoroalkyl substances exposure and thyroid function biomarkers among females attending a fertility clinic

PFAS exposure exert negative effects on oocyte yield, fertilization and high-quality embryo in women undergoing IVF

Exposure to Polycyclic Aromatic Hydrocarbons and Risk for Premature Ovarian Failure and Reproductive Hormones Imbalance

Early pregnancy loss: Do Per- and polyfluoroalkyl substances matter?

Perfluoroalkyl Substances and Endometriosis-Related Infertility in Chinese Women.

Associations of per- and polyfluoroalkyl substances with maternal early second trimester sex-steroid hormones

Associations of per- and polyfluoroalkyl substances with maternal metabolic and inflammatory biomarkers in early-to-mid-pregnancy

Environmental Exposure to Emerging Alternatives of Per- and Polyfluoroalkyl Substances and Polycystic Ovarian Syndrome in Women Diagnosed with Infertility: A Mixture Analysis

Perfluorinated Compounds and Subfecundity in Pregnant Women